Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
Tamar Melkadze, Valery Breder, Jose David Gomez Rangel, Fawzi Benzaghou, Gontran Verset, Robin Kate Kelley, Steven Milwee, Wattana Sukeepaisarnjaroen, Dominic Curran, Philippe Merle, Tamta Makharadze, Baek-Yeol Ryoo, Stephen L Chan, Ahmed Kaseb, Andrew X Zhu, Lorenza Rimassa, Ivan Borbath, Thomas Yau, Ann-Lii Cheng, Shukui Qin, Zhong Wang, Edward Gane
The lancet. Gastroenterology & hepatology 2024;9(4):310-322